mRNA |
AZD6482 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0004 |
mRNA |
Tamoxifen |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.001 |
mRNA |
CHIR-99021 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.001 |
mRNA |
GSK2636771 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.002 |
mRNA |
TGX221 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.003 |
mRNA |
Cytarabine |
GDSC1000 |
pan-cancer |
AAC |
-0.1 |
0.004 |
mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.32 |
0.005 |
mRNA |
PD-0332991 |
GDSC1000 |
pan-cancer |
AAC |
-0.095 |
0.006 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.089 |
0.008 |
mRNA |
Rapamycin |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.01 |